Intellipharmaceutics International

Intellipharmaceutics Update on its Oxycodone ER New Drug Application

Intellipharmaceutics Update on its Oxycodone ER New Drug Application :: Intellipharmaceutics International Inc. (IPCIF) Download as PDF October 24, 2019 TORONTO, ON / ACCESSWIRE / October 24, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic control...

Intellipharmaceutics Announces an Update in the Purdue Litigation

Intellipharmaceutics Announces an Update in the Purdue Litigation :: Intellipharmaceutics International Inc. (IPCIF) Download as PDF October 04, 2019 TORONTO, ONTARIO / ACCESSWIRE / October 4, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic contro...

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. :: Intellipharmaceutics International Inc. (IPCIF) Download as PDF August 15, 2019 TORONTO, ON / ACCESSWIRE / August 15, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic c...

Intellipharmaceutics Announces Second Quarter 2019 Results

https://www.intellipharmaceutics.com/news-media/press-releases/detail/206/intellipharmaceutics-announces-second-quarter-2019-results

Intellipharmaceutics Announces Second Quarter 2019 Results :: Intellipharmaceutics International Inc. (IPCIF) Download as PDF July 10, 2019 TORONTO, ON / ACCESSWIRE / July 10, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic con...